期刊
UROLOGIC CLINICS OF NORTH AMERICA
卷 30, 期 2, 页码 219-+出版社
W B SAUNDERS CO
DOI: 10.1016/S0094-0143(02)00182-9
关键词
-
资金
- AHRQ HHS [HS09578] Funding Source: Medline
Predicting the long-term outcome of patients who choose watchful waiting as their initial therapy for prostate cancer is difficult. The wide variation in disease progression, the impact of competing medical hazards, and the potential impact of early hormonal therapy that is characteristic of contemporary patients all conspire to compromise survival estimates dating from the pre-prostate-specific antigen (PSA) era. This article reviews the key research that has contributed to the understanding of the natural history of prostate cancer and explores the impact of PSA testing on long-term outcomes. Special attention is given to prostate cancer summary statistics, because these numbers have been impacted by the introduction of testing for PSA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据